Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Legend Biotech Corporation Sponsored ADR (LEGN) had Debt to Equity Ratio of 0.37 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$255.06M |
|
$-125.38M |
|
$97.99M |
|
$157.07M |
|
$385.07M |
|
$-130.01M |
|
$5.21M |
|
$-124.80M |
|
$-124.80M |
|
$-125.38M |
|
$-125.38M |
|
$-125.38M |
|
$-125.38M |
|
$-130.01M |
|
$-124.16M |
|
184.14M |
|
184.14M |
|
$-0.68 |
|
$-0.68 |
|
| Balance Sheet Financials | |
$1.25B |
|
$106.38M |
|
$440.04M |
|
$1.69B |
|
$265.48M |
|
$310.26M |
|
$388.89M |
|
$654.38M |
|
$1.04B |
|
$1.03B |
|
$1.04B |
|
184.57M |
|
| Cash Flow Statement Financials | |
$-116.80M |
|
$91.11M |
|
$-0.32M |
|
$286.75M |
|
$266.59M |
|
$-20.16M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.71 |
|
-- |
|
-- |
|
0.23 |
|
|
Debt to Equity Ratio |
0.37 |
61.58% |
|
-50.97% |
|
-50.97% |
|
-- |
|
-48.93% |
|
-49.16% |
|
$-128.02M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
2.75 |
|
9.25 |
|
9.73 |
|
-12.11% |
|
-12.13% |
|
-7.42% |
|
-9.32% |
|
$5.61 |
|
$-0.70 |
|
$-0.63 |
|